Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing

Mohamed Ayoub1, Kambis Mashayekhi2, Michael Behnes3

  • 1Division of Cardiology and Angiology, Heart Center University of Bochum, 32545 Bad Oeynhausen, Germany.

PubMed

Insights

High uric acid levels predict mortality in patients undergoing percutaneous coronary intervention for chronic total occlusions. Incorporating uric acid into risk assessment may improve outcomes for these patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • Uric acid (UA) is increasingly recognized as a potential predictor of clinical outcomes after percutaneous coronary intervention (PCI).
  • The prognostic significance of UA in patients undergoing PCI specifically for chronic total occlusions (CTO) remains underexplored.

Purpose of the Study:

  • To investigate the association between pre-procedural uric acid levels and clinical outcomes in patients with CTO undergoing PCI.
  • To determine if uric acid is an independent predictor of all-cause mortality in this specific patient population.

Main Methods:

  • A retrospective analysis of 1963 patients with CTO who underwent PCI between 2005 and 2012.
  • Patients were stratified into three groups based on pre-angiography uric acid tertiles (<5.5 mg/dL, 5.6-6.9 mg/dL, >7.0 mg/dL).
  • Outcomes, including all-cause mortality, were compared among the uric acid tertiles with a median follow-up of 3.0 years.

Main Results:

  • Patients in the lowest uric acid tertile (<5.5 mg/dL) had significantly lower all-cause mortality compared to the highest tertile (>7.0 mg/dL) (adjusted HR: 0.67; 95% CI: 0.49-0.92; p=0.012).
  • No significant difference in all-cause mortality was observed between the first and second uric acid tertiles (adjusted HR: 0.96; 95% CI: 0.71-1.3; p=0.78).
  • Elevated uric acid levels were identified as an independent predictor of all-cause mortality in patients with CTO treated with PCI.

Conclusions:

  • High serum uric acid levels are associated with increased all-cause mortality in patients with chronic total occlusions undergoing percutaneous coronary intervention.
  • Uric acid measurement should be considered as part of the routine risk stratification for patients with CTO undergoing PCI.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13